Analysts expect Editas Medicine, Inc. to report revenue of 4.40 M for Q3 26, against a range of 4.06 M to 4.73 M. The most recent reported quarter, Q2 26, came in at 11.89 M, a 326.0% beat against the 2.79 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 61,000.00 | 30.60 M | 4.66 M | 3.58 M | 7.54 M | 24.74 M | 2.83 M | 11.89 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 4.37 M | 30.18 M | 645,966.13 | 2.53 M | 4.95 M | 9.64 M | 6.90 M | 2.88 M | 4.73 M | 7.30 M | 3.22 M | 3.51 M | 13.98 M | 25.02 M | 1.05 M | 1.59 M | ||||||||||
| Low Estimate | 3.65 M | 27.34 M | 570,177.29 | 2.25 M | 4.26 M | 7.91 M | 6.12 M | 2.70 M | 4.06 M | 6.18 M | 2.80 M | 3.15 M | 12.30 M | 21.83 M | 900,011.73 | 1.40 M | ||||||||||
| Consensus Estimate | 4.01 M | 28.76 M | 608,071.71 | 2.39 M | 4.60 M | 8.77 M | 6.51 M | 2.79 M | 4.40 M | 6.74 M | 3.01 M | 3.33 M | 13.14 M | 23.43 M | 974,862.66 | 1.49 M |
Analysts expect Editas Medicine, Inc. to report earnings per share of -0.18 for Q3 26, against a range of -0.19 to -0.17. The most recent reported quarter, Q2 26, came in at -0.15, a 40.0% beat against the -0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.75 | -0.55 | -0.92 | -0.63 | -0.28 | -0.06 | -0.26 | -0.15 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.65 | -0.35 | -0.54 | -0.39 | -0.27 | -0.23 | -0.22 | -0.23 | -0.17 | -0.18 | -0.15 | -0.18 | -0.06 | -0.03 | -0.30 | -0.24 | ||||||||||
| Low Estimate | -0.75 | -0.37 | -0.62 | -0.45 | -0.31 | -0.25 | -0.26 | -0.27 | -0.19 | -0.20 | -0.19 | -0.20 | -0.06 | -0.03 | -0.34 | -0.26 | ||||||||||
| Consensus Estimate | -0.70 | -0.36 | -0.58 | -0.42 | -0.29 | -0.24 | -0.24 | -0.25 | -0.18 | -0.19 | -0.17 | -0.19 | -0.06 | -0.03 | -0.32 | -0.25 |
Pull Wall Street consensus for Editas Medicine, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=EDIT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "EDIT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=EDIT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();